Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 66 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 7619057

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted

  2. US 7612044

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  3. US 7605125

    DNA-binding polyamide drug conjugates

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

  4. US 7598225

    Generation of immune response to prostate-specific antigen (PSA)

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  5. US 7598077

    Compositions and methods for enhancing differential expression

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  6. US 7585667

    Negative strand RNA virus replicon

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  7. US 7585841

    Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  8. US 7576050

    GLP-1 exendin-4 peptide analogs and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted

  9. US 7572771

    Multi-domain amphipathic helical peptides and methods of their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  10. US 7572887

    Gene expressed in prostate cancer, methods and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  11. US 7569673

    Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  12. US 7566451

    Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  13. US 7560118

    Attenuated dengue virus comprising mutations in the NS3 gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  14. US 7547773

    Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  15. US 7547762

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  16. US 7544789

    DNA encoding Toxoplasma gondii rDGP5p protein

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  17. US 7541034

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  18. US 7541043

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  19. US 7541139

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  20. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted May 26, 2009 · Expires May 21, 2029

    granted

  21. US 7534565

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted May 19, 2009 · Expires May 14, 2029

    granted

  22. US 7531352

    Inducible plasmid vector encoding TGF-β and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 12, 2009 · Expires May 7, 2029

    granted

  23. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  24. US 7524508

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.